Global Non-Insulin Therapies for Diabetes Market Research Report 2017

January 2017 | 123 pages | ID: G12BB4040AEEN
QYResearch

Abstracts

Notes:

Production, means the output of Non-Insulin Therapies for Diabetes

Revenue, means the sales value of Non-Insulin Therapies for Diabetes

This report studies Non-Insulin Therapies for Diabetes in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering

• GSK
• Eli Lilly
• Sumitomo Dainippon Pharma
• Intarcia Therapeutics
• Servier
• Jiangsu Hansoh Pharmaceutical
• Novo Nordisk
• Emisphere
• Uni-Bio Science Group
• Takeda
• 3SBio
• Merck
• Dong-A Pharmaceutical
• Luye Pharma Group
• Eurofarma
• Geropharm
• Alkem Labs
• SatRx
• Pfizer
• Jiangsu Hengrui Medicine

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Non-Insulin Therapies for Diabetes in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Alpha-Glucosidase Inhibitors
• Amylin Agonists
• Biguanides
• Dipeptidyl Peptidase-4 (DPP4) Inhibitors
• Glinides/Meglitinides
• GLP-1 Analogs/GLP-1 Agonists
• Sodium-Glucose Cotransporter2(SGLT2)Inhibitors
• Sulfonylureas
• Thiazolidinediones
• Others

Split by application, this report focuses on consumption, market share and growth rate of Non-Insulin Therapies for Diabetes in each application, can be divided into

• Hospital Pharmacy
• Retail Pharmacies
• Online Pharmacy
• Others

Contents

Global Non-Insulin Therapies for Diabetes Market Research Report 2017

1 NON-INSULIN THERAPIES FOR DIABETES MARKET OVERVIEW

1.1 Product Overview and Scope of Non-Insulin Therapies for Diabetes
1.2 Non-Insulin Therapies for Diabetes Segment by Type
  1.2.1 Global Production Market Share of Non-Insulin Therapies for Diabetes by Type in 2015
  1.2.2 Alpha-Glucosidase Inhibitors
  1.2.3 Amylin Agonists
  1.2.4 Biguanides
  1.2.5 Dipeptidyl Peptidase-4 (DPP4) Inhibitors
  1.2.6 Glinides/Meglitinides
  1.2.7 GLP-1 Analogs/GLP-1 Agonists
  1.2.8 Sodium-Glucose Cotransporter2(SGLT2)Inhibitors
  1.2.9 Sulfonylureas
  1.2.10 Thiazolidinediones
  1.2.11 Others
1.3 Non-Insulin Therapies for Diabetes Segment by Application
  1.3.1 Non-Insulin Therapies for Diabetes Consumption Market Share by Application in 2015
  1.3.2 Hospital Pharmacy
  1.3.3 Retail Pharmacies
  1.3.4 Online Pharmacy
  1.3.5 Others
1.4 Non-Insulin Therapies for Diabetes Market by Region
  1.4.1 North America Status and Prospect (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 China Status and Prospect (2012-2022)
  1.4.4 Japan Status and Prospect (2012-2022)
  1.4.5 Southeast Asia Status and Prospect (2012-2022)
  1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Non-Insulin Therapies for Diabetes (2012-2022)

2 GLOBAL NON-INSULIN THERAPIES FOR DIABETES MARKET COMPETITION BY MANUFACTURERS

2.1 Global Non-Insulin Therapies for Diabetes Production and Share by Manufacturers (2015 and 2016)
2.2 Global Non-Insulin Therapies for Diabetes Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Non-Insulin Therapies for Diabetes Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Non-Insulin Therapies for Diabetes Manufacturing Base Distribution, Sales Area and Product Type
2.5 Non-Insulin Therapies for Diabetes Market Competitive Situation and Trends
  2.5.1 Non-Insulin Therapies for Diabetes Market Concentration Rate
  2.5.2 Non-Insulin Therapies for Diabetes Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL NON-INSULIN THERAPIES FOR DIABETES PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

3.1 Global Non-Insulin Therapies for Diabetes Production and Market Share by Region (2012-2017)
3.2 Global Non-Insulin Therapies for Diabetes Revenue (Value) and Market Share by Region (2012-2017)
3.3 Global Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2012-2017)
3.4 North America Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2012-2017)
3.5 Europe Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2012-2017)
3.6 China Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2012-2017)
3.7 Japan Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Southeast Asia Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2012-2017)
3.9 India Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2012-2017)

4 GLOBAL NON-INSULIN THERAPIES FOR DIABETES SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)

4.1 Global Non-Insulin Therapies for Diabetes Consumption by Regions (2012-2017)
4.2 North America Non-Insulin Therapies for Diabetes Production, Consumption, Export, Import (2012-2017)
4.3 Europe Non-Insulin Therapies for Diabetes Production, Consumption, Export, Import (2012-2017)
4.4 China Non-Insulin Therapies for Diabetes Production, Consumption, Export, Import (2012-2017)
4.5 Japan Non-Insulin Therapies for Diabetes Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Non-Insulin Therapies for Diabetes Production, Consumption, Export, Import (2012-2017)
4.7 India Non-Insulin Therapies for Diabetes Production, Consumption, Export, Import (2012-2017)

5 GLOBAL NON-INSULIN THERAPIES FOR DIABETES PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Non-Insulin Therapies for Diabetes Production and Market Share by Type (2012-2017)
5.2 Global Non-Insulin Therapies for Diabetes Revenue and Market Share by Type (2012-2017)
5.3 Global Non-Insulin Therapies for Diabetes Price by Type (2012-2017)
5.4 Global Non-Insulin Therapies for Diabetes Production Growth by Type (2012-2017)

6 GLOBAL NON-INSULIN THERAPIES FOR DIABETES MARKET ANALYSIS BY APPLICATION

6.1 Global Non-Insulin Therapies for Diabetes Consumption and Market Share by Application (2012-2017)
6.2 Global Non-Insulin Therapies for Diabetes Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL NON-INSULIN THERAPIES FOR DIABETES MANUFACTURERS PROFILES/ANALYSIS

7.1 GSK
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
    7.1.2.1 Alpha-Glucosidase Inhibitors
    7.1.2.2 Amylin Agonists
  7.1.3 GSK Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Eli Lilly
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
    7.2.2.1 Alpha-Glucosidase Inhibitors
    7.2.2.2 Amylin Agonists
  7.2.3 Eli Lilly Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Sumitomo Dainippon Pharma
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
    7.3.2.1 Alpha-Glucosidase Inhibitors
    7.3.2.2 Amylin Agonists
  7.3.3 Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Intarcia Therapeutics
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
    7.4.2.1 Alpha-Glucosidase Inhibitors
    7.4.2.2 Amylin Agonists
  7.4.3 Intarcia Therapeutics Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Servier
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
    7.5.2.1 Alpha-Glucosidase Inhibitors
    7.5.2.2 Amylin Agonists
  7.5.3 Servier Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Jiangsu Hansoh Pharmaceutical
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
    7.6.2.1 Alpha-Glucosidase Inhibitors
    7.6.2.2 Amylin Agonists
  7.6.3 Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Novo Nordisk
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
    7.7.2.1 Alpha-Glucosidase Inhibitors
    7.7.2.2 Amylin Agonists
  7.7.3 Novo Nordisk Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Emisphere
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
    7.8.2.1 Alpha-Glucosidase Inhibitors
    7.8.2.2 Amylin Agonists
  7.8.3 Emisphere Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 Uni-Bio Science Group
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
    7.9.2.1 Alpha-Glucosidase Inhibitors
    7.9.2.2 Amylin Agonists
  7.9.3 Uni-Bio Science Group Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Takeda
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Non-Insulin Therapies for Diabetes Product Type, Application and Specification
    7.10.2.1 Alpha-Glucosidase Inhibitors
    7.10.2.2 Amylin Agonists
  7.10.3 Takeda Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 3SBio
7.12 Merck
7.13 Dong-A Pharmaceutical
7.14 Luye Pharma Group
7.15 Eurofarma
7.16 Geropharm
7.17 Alkem Labs
7.18 SatRx
7.19 Pfizer
7.20 Jiangsu Hengrui Medicine

8 NON-INSULIN THERAPIES FOR DIABETES MANUFACTURING COST ANALYSIS

8.1 Non-Insulin Therapies for Diabetes Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Non-Insulin Therapies for Diabetes

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Non-Insulin Therapies for Diabetes Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Non-Insulin Therapies for Diabetes Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL NON-INSULIN THERAPIES FOR DIABETES MARKET FORECAST (2017-2022)

12.1 Global Non-Insulin Therapies for Diabetes Production, Revenue and Price Forecast (2017-2022)
  12.1.1 Global Non-Insulin Therapies for Diabetes Production and Growth Rate Forecast (2017-2022)
  12.1.2 Global Non-Insulin Therapies for Diabetes Revenue and Growth Rate Forecast (2017-2022)
  12.1.3 Global Non-Insulin Therapies for Diabetes Price and Trend Forecast (2017-2022)
12.2 Global Non-Insulin Therapies for Diabetes Production, Consumption, Import and Export Forecast by Regions (2017-2022)
  12.2.1 North America Non-Insulin Therapies for Diabetes Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.2 Europe Non-Insulin Therapies for Diabetes Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.3 China Non-Insulin Therapies for Diabetes Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.4 Japan Non-Insulin Therapies for Diabetes Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.5 Southeast Asia Non-Insulin Therapies for Diabetes Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
  12.2.6 India Non-Insulin Therapies for Diabetes Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Non-Insulin Therapies for Diabetes Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Non-Insulin Therapies for Diabetes Consumption Forecast by Application (2017-2022)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Non-Insulin Therapies for Diabetes
Figure Global Production Market Share of Non-Insulin Therapies for Diabetes by Type in 2015
Figure Product Picture of Alpha-Glucosidase Inhibitors
Table Major Manufacturers of Alpha-Glucosidase Inhibitors
Figure Product Picture of Amylin Agonists
Table Major Manufacturers of Amylin Agonists
Figure Product Picture of Biguanides
Table Major Manufacturers of Biguanides
Figure Product Picture of Dipeptidyl Peptidase-4 (DPP4) Inhibitors
Table Major Manufacturers of Dipeptidyl Peptidase-4 (DPP4) Inhibitors
Figure Product Picture of Glinides/Meglitinides
Table Major Manufacturers of Glinides/Meglitinides
Figure Product Picture of GLP-1 Analogs/GLP-1 Agonists
Table Major Manufacturers of GLP-1 Analogs/GLP-1 Agonists
Figure Product Picture of Sodium-Glucose Cotransporter2(SGLT2)Inhibitors
Table Major Manufacturers of Sodium-Glucose Cotransporter2(SGLT2)Inhibitors
Figure Product Picture of Sulfonylureas
Table Major Manufacturers of Sulfonylureas
Figure Product Picture of Thiazolidinediones
Table Major Manufacturers of Thiazolidinediones
Figure Product Picture of Others
Table Major Manufacturers of Others
Table Non-Insulin Therapies for Diabetes Consumption Market Share by Application in 2015
Figure Hospital Pharmacy Examples
Figure Retail Pharmacies Examples
Figure Online Pharmacy Examples
Figure Others Examples
Figure North America Non-Insulin Therapies for Diabetes Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Non-Insulin Therapies for Diabetes Revenue (Million USD) and Growth Rate (2012-2022)
Figure China Non-Insulin Therapies for Diabetes Revenue (Million USD) and Growth Rate (2012-2022)
Figure Japan Non-Insulin Therapies for Diabetes Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southeast Asia Non-Insulin Therapies for Diabetes Revenue (Million USD) and Growth Rate (2012-2022)
Figure India Non-Insulin Therapies for Diabetes Revenue (Million USD) and Growth Rate (2012-2022)
Figure Global Non-Insulin Therapies for Diabetes Revenue (Million UDS) and Growth Rate (2012-2022)
Table Global Non-Insulin Therapies for Diabetes Production of Key Manufacturers (2015 and 2016)
Table Global Non-Insulin Therapies for Diabetes Production Share by Manufacturers (2015 and 2016)
Figure 2015 Non-Insulin Therapies for Diabetes Production Share by Manufacturers
Figure 2016 Non-Insulin Therapies for Diabetes Production Share by Manufacturers
Table Global Non-Insulin Therapies for Diabetes Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Non-Insulin Therapies for Diabetes Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Non-Insulin Therapies for Diabetes Revenue Share by Manufacturers
Table 2016 Global Non-Insulin Therapies for Diabetes Revenue Share by Manufacturers
Table Global Market Non-Insulin Therapies for Diabetes Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Non-Insulin Therapies for Diabetes Average Price of Key Manufacturers in 2015
Table Manufacturers Non-Insulin Therapies for Diabetes Manufacturing Base Distribution and Sales Area
Table Manufacturers Non-Insulin Therapies for Diabetes Product Type
Figure Non-Insulin Therapies for Diabetes Market Share of Top 3 Manufacturers
Figure Non-Insulin Therapies for Diabetes Market Share of Top 5 Manufacturers
Table Global Non-Insulin Therapies for Diabetes Production by Regions (2012-2017)
Figure Global Non-Insulin Therapies for Diabetes Production and Market Share by Regions (2012-2017)
Figure Global Non-Insulin Therapies for Diabetes Production Market Share by Regions (2012-2017)
Figure 2015 Global Non-Insulin Therapies for Diabetes Production Market Share by Regions
Table Global Non-Insulin Therapies for Diabetes Revenue by Regions (2012-2017)
Table Global Non-Insulin Therapies for Diabetes Revenue Market Share by Regions (2012-2017)
Table 2015 Global Non-Insulin Therapies for Diabetes Revenue Market Share by Regions
Table Global Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2012-2017)
Table North America Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2012-2017)
Table Europe Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2012-2017)
Table China Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2012-2017)
Table Japan Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2012-2017)
Table Southeast Asia Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2012-2017)
Table India Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2012-2017)
Table Global Non-Insulin Therapies for Diabetes Consumption Market by Regions (2012-2017)
Table Global Non-Insulin Therapies for Diabetes Consumption Market Share by Regions (2012-2017)
Figure Global Non-Insulin Therapies for Diabetes Consumption Market Share by Regions (2012-2017)
Figure 2015 Global Non-Insulin Therapies for Diabetes Consumption Market Share by Regions
Table North America Non-Insulin Therapies for Diabetes Production, Consumption, Import & Export (2012-2017)
Table Europe Non-Insulin Therapies for Diabetes Production, Consumption, Import & Export (2012-2017)
Table China Non-Insulin Therapies for Diabetes Production, Consumption, Import & Export (2012-2017)
Table Japan Non-Insulin Therapies for Diabetes Production, Consumption, Import & Export (2012-2017)
Table Southeast Asia Non-Insulin Therapies for Diabetes Production, Consumption, Import & Export (2012-2017)
Table India Non-Insulin Therapies for Diabetes Production, Consumption, Import & Export (2012-2017)
Table Global Non-Insulin Therapies for Diabetes Production by Type (2012-2017)
Table Global Non-Insulin Therapies for Diabetes Production Share by Type (2012-2017)
Figure Production Market Share of Non-Insulin Therapies for Diabetes by Type (2012-2017)
Figure 2015 Production Market Share of Non-Insulin Therapies for Diabetes by Type
Table Global Non-Insulin Therapies for Diabetes Revenue by Type (2012-2017)
Table Global Non-Insulin Therapies for Diabetes Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Non-Insulin Therapies for Diabetes by Type (2012-2017)
Figure 2015 Revenue Market Share of Non-Insulin Therapies for Diabetes by Type
Table Global Non-Insulin Therapies for Diabetes Price by Type (2012-2017)
Figure Global Non-Insulin Therapies for Diabetes Production Growth by Type (2012-2017)
Table Global Non-Insulin Therapies for Diabetes Consumption by Application (2012-2017)
Table Global Non-Insulin Therapies for Diabetes Consumption Market Share by Application (2012-2017)
Figure Global Non-Insulin Therapies for Diabetes Consumption Market Share by Application in 2015
Table Global Non-Insulin Therapies for Diabetes Consumption Growth Rate by Application (2012-2017)
Figure Global Non-Insulin Therapies for Diabetes Consumption Growth Rate by Application (2012-2017)
Table GSK Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GSK Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure GSK Non-Insulin Therapies for Diabetes Market Share (2015 and 2016)
Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Eli Lilly Non-Insulin Therapies for Diabetes Market Share (2015 and 2016)
Table Sumitomo Dainippon Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Sumitomo Dainippon Pharma Non-Insulin Therapies for Diabetes Market Share (2015 and 2016)
Table Intarcia Therapeutics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Intarcia Therapeutics Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Intarcia Therapeutics Non-Insulin Therapies for Diabetes Market Share (2015 and 2016)
Table Servier Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Servier Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Servier Non-Insulin Therapies for Diabetes Market Share (2015 and 2016)
Table Jiangsu Hansoh Pharmaceutical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Jiangsu Hansoh Pharmaceutical Non-Insulin Therapies for Diabetes Market Share (2015 and 2016)
Table Novo Nordisk Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Novo Nordisk Non-Insulin Therapies for Diabetes Market Share (2015 and 2016)
Table Emisphere Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Emisphere Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Emisphere Non-Insulin Therapies for Diabetes Market Share (2015 and 2016)
Table Uni-Bio Science Group Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Uni-Bio Science Group Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Uni-Bio Science Group Non-Insulin Therapies for Diabetes Market Share (2015 and 2016)
Table Takeda Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Takeda Non-Insulin Therapies for Diabetes Production, Revenue, Price and Gross Margin (2015 and 2016)
Figure Takeda Non-Insulin Therapies for Diabetes Market Share (2015 and 2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Non-Insulin Therapies for Diabetes
Figure Manufacturing Process Analysis of Non-Insulin Therapies for Diabetes
Figure Non-Insulin Therapies for Diabetes Industrial Chain Analysis
Table Raw Materials Sources of Non-Insulin Therapies for Diabetes Major Manufacturers in 2015
Table Major Buyers of Non-Insulin Therapies for Diabetes
Table Distributors/Traders List
Figure Global Non-Insulin Therapies for Diabetes Production and Growth Rate Forecast (2017-2022)
Figure Global Non-Insulin Therapies for Diabetes Revenue and Growth Rate Forecast (2017-2022)
Figure Global Non-Insulin Therapies for Diabetes Price and Trend Forecast (2017-2022)
Table Global Non-Insulin Therapies for Diabetes Production Forecast by Regions (2017-2022)
Table Global Non-Insulin Therapies for Diabetes Consumption Forecast by Regions (2017-2022)
Figure North America Non-Insulin Therapies for Diabetes Production, Revenue and Growth Rate Forecast (2017-2022)
Table North America Non-Insulin Therapies for Diabetes Production, Consumption, Export and Import Forecast (2017-2022)
Figure Europe Non-Insulin Therapies for Diabetes Production, Revenue and Growth Rate Forecast (2017-2022)
Table Europe Non-Insulin Therapies for Diabetes Production, Consumption, Export and Import Forecast (2017-2022)
Figure China Non-Insulin Therapies for Diabetes Production, Revenue and Growth Rate Forecast (2017-2022)
Table China Non-Insulin Therapies for Diabetes Production, Consumption, Export and Import Forecast (2017-2022)
Figure Japan Non-Insulin Therapies for Diabetes Production, Revenue and Growth Rate Forecast (2017-2022)
Table Japan Non-Insulin Therapies for Diabetes Production, Consumption, Export and Import Forecast (2017-2022)
Figure Southeast Asia Non-Insulin Therapies for Diabetes Production, Revenue and Growth Rate Forecast (2017-2022)
Table Southeast Asia Non-Insulin Therapies for Diabetes Production, Consumption, Export and Import Forecast (2017-2022)
Figure India Non-Insulin Therapies for Diabetes Production, Revenue and Growth Rate Forecast (2017-2022)
Table India Non-Insulin Therapies for Diabetes Production, Consumption, Export and Import Forecast (2017-2022)
Table Global Non-Insulin Therapies for Diabetes Production Forecast by Type (2017-2022)
Table Global Non-Insulin Therapies for Diabetes Revenue Forecast by Type (2017-2022)
Table Global Non-Insulin Therapies for Diabetes Price Forecast by Type (2017-2022)
Table Global Non-Insulin Therapies for Diabetes Consumption Forecast by Application (2017-2022)